Substance Abuse Treatment Advisory Spring 2007 Vol 6 Issue 1:Naltrexone for Extended-Release Injectable Suspension for Treatment of Alcohol Dependence

Substance Abuse Treatment Advisory Spring 2007 Vol 6 Issue 1:Naltrexone for Extended-Release Injectable Suspension for Treatment of Alcohol Dependence

In April 2006, the U.S. Food and Drug Administration approved a new extended-release injectable formulation of naltrexone (Vivitrol®) for the treatment of alcohol dependence. This issue of Substance Abuse Treatment Advisory answers questions treatment providers, particularly counselors and program administrators, may have about injectable naltrexone.


View Materials in PDF Format (6 páginas, 397kb)
http://download.ncadi.samhsa.gov/prevline/pdfs/SMA07-4267.pdf

o bien, abrir aquí para acceder al documento SAMHSA:
Substance Abuse Treatment Advisory Spring 2007 Vol 6 Issue 1:Naltrexone for Extended-Release Injectable Suspension for Treatment of Alcohol Dependence